Finally, adoptive transfer of wild type or IL-13-deficient ILC2s into DSS-treated ILC2-deficient Apc1322T+ mice confirmed that ILC2-derived IL-13 was critical in promoting colonic tumor Arg1+ M-MDSCs (Fig. 7M and fig. The gene discussed is IL13; the disease is colonic neoplasm.